Indaptus Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Indaptus Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
  • Indaptus Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 465 %, a 47.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 465 -420 -47.5% Sep 30, 2024
Q2 2024 565 -400 -41.5% Jun 30, 2024
Q1 2024 695 -260 -27.2% Mar 31, 2024
Q4 2023 804 -129 -13.8% Dec 31, 2023
Q3 2023 886 -62.3 -6.57% Sep 30, 2023
Q2 2023 965 +92.4 +10.6% Jun 30, 2023
Q1 2023 955 +237 +33% Mar 31, 2023
Q4 2022 933 Dec 31, 2022
Q3 2022 948 Sep 30, 2022
Q2 2022 873 Jun 30, 2022
Q1 2022 718 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.